12:00 AM
 | 
Oct 11, 2016
 |  BC Extra  |  Company News

Management tracks

Musculoskeletal company Bone Therapeutics S.A. (Euronext:BOTHE) said CEO Enrico Bastianelli will depart for personal reasons. CBO Thomas Lienard will be interim CEO.

Specialty pharma EffRx Pharmaceuticals S.A. (Lausanne, Switzerland) promoted Lorenzo Bosisio to CEO. He was chief commercial officer.

Inflammation company Reata Pharmaceuticals Inc. (NASDAQ:RETA) hired Dawn Carter Bir...

Read the full 250 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >